Exact Sciences shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and announced a $90 price target.
Portfolio Pulse from Benzinga Newsdesk
Exact Sciences shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and announced a $90 price target.
October 10, 2023 | 6:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler upgraded Exact Sciences from Neutral to Overweight and set a $90 price target, leading to a rise in the company's shares.
The upgrade from Piper Sandler is a positive signal for Exact Sciences. The new Overweight rating suggests that the firm believes EXAS will outperform the market, which is likely to attract investors and drive the stock price up. The $90 price target also indicates a positive outlook for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100